$1.08 Billion is the total value of BRIDGER MANAGEMENT, LLC's 35 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNC | Buy | CENTENE CORP DEL | $57,160,000 | +7.3% | 899,448 | +0.3% | 5.29% | -14.2% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $54,579,000 | +288.5% | 328,571 | +195.6% | 5.05% | +210.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $53,206,000 | +40.6% | 359,234 | +3.4% | 4.93% | +12.5% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $33,790,000 | +342.6% | 536,782 | +195.3% | 3.13% | +254.4% |
| UBER | New | UBER TECHNOLOGIES INC | $20,202,000 | – | 650,000 | +100.0% | 1.87% | – |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $19,846,000 | +27.3% | 1,923,033 | +24.5% | 1.84% | +1.9% |
| DXCM | Buy | DEXCOM INC | $15,369,000 | +146.2% | 37,910 | +63.5% | 1.42% | +97.1% |
| INSP | New | INSPIRE MED SYS INC | $14,501,000 | – | 166,636 | +100.0% | 1.34% | – |
| FTDR | New | FRONTDOOR INC | $9,974,000 | – | 225,000 | +100.0% | 0.92% | – |
| BMYRT | New | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $6,537,000 | – | 1,826,003 | +100.0% | 0.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.